Characterization of Agrin/LRP4 Antibody Positive Myasthenia Gravis
Diseases of the Nervous System
What is the purpose of this trial?
Agrin and LRP4 antibodies have been detected in blood of MG patients. but a direct link with these antibodies and MG is not yet firmly established. The purpose of this study is to determine whether there is a relationship between Agrin and LRP4 antibodies in MG patients to their clinical features, disease severity, and how they have responded to treatments.
If you agree to participate in this study, the following procedures will occur: Review of your medical records, such as: MRI, EMG, X-Ray, CT Scan, current medications, treatments you have used to treat your MG; lumbar puncture; family history; breathing tests; blood draws; neurological exam; physical exam.
- Ages21 years and older
- Trial withAugusta University
- Start Date08/10/2016
- End Date03/31/2020
- Last Updated02/22/2018
- Study HIC#1603017470